2026 International Spring Forum
April 15, 2026 | 12:00 PM EST
- Home
- Clinical Resources Search
- PQI: Sacituzumab govitecan-hziy (Trodelvy®): Prophylaxis and Management of Adverse Events
Sacituzumab govitecan-hziy (Trodelvy®): Prophylaxis and Management of Adverse Events
About this PQI
The purpose of this PQI is to provide information on the management of common adverse events of sacituzumab govitecan-hziy including diarrhea and neutropenia, as well as prophylaxis of nausea and vomiting.
More About This PQI
PQI in Action Articles:
How to Use a Positive Quality Intervention (PQI)
Essentially, it’s a tool to improve patient care by sharing best practices in oncology care.
Consider this standardized, peer-review clinical guidance to oncology healthcare teams, enabling you and your team to consistently deliver high-quality care to your patients.
Find a PQIFind Similar Resources
All Resources
PQI
PQI
PQI
PQI
PQI: HER2 Immunohistochemistry Testing in Metastatic Breast Cancer: Guiding Treatment Decisions and the Role of Sacituzumab Govitecan
Last Updated: 02/04/2026
PQI: Ivosidenib (Tibsovo) and Management of IDH1 Mutant Acute Myeloid Leukemia
Last Updated: 10/07/2025
PQI: Datopotamab deruxtecan (Datroway): Prophylaxis and Management of Adverse Events
Last Updated: 10/07/2025
PQI: Streamlining Enrollment in the Medicare Prescription Payment Plan (MPPP)
Last Updated: 09/17/2025
PQI in Action
PQI in Action
PQI in Action
PQI in Action
PQI in Action: Darolutamide (Nubeqa)
Last Updated: 01/22/2026
PQI in Action: Zolbetuximab (Vyloy) for Gastroesophageal Cancers
Last Updated: 12/17/2025
PQI in Action: Epcoritamab (Epkinly) for Relapsed/Refractory Diffuse Large B-Cell Lymphoma and Follicular Lymphoma
Last Updated: 10/09/2025
PQI in Action: Nirogacestat (Ogsiveo) use in Management of Adults with Progressing Desmoid Tumors (or fibromatosis or aggressive fibromatosis)
Last Updated: 10/04/2025
PQI Podcast
PQI Podcast
PQI Podcast
PQI Podcast
S9 Bonus Episode: From Patient to MIP Advocate
Last Updated: 01/22/2026
S9 E15: Theranostics: The New Era of Targeted Imaging & Therapy
Last Updated: 12/18/2025
S9 E14: Immunotherapy and the MyMelanoma Project
Last Updated: 12/11/2025
S9 E13: A Season of Gratitude
Last Updated: 12/02/2025
Toolkit
Toolkit
Toolkit: Simplify CLL Tracking in Oncology Practices
Last Updated: 10/15/2025
Toolkit: Optimize CLL Care in Epic
Last Updated: 10/15/2025
Treatment Support Kit
Treatment Support Kit
Treatment Support Kit
Treatment Support Kit
Treatment Support Kit: Elranatamab
Last Updated: 01/06/2026
Treatment Support Kit: Bi-Specific
Last Updated: 12/12/2025
Treatment Support Kit: Mirdametinib
Last Updated: 06/10/2025
Treatment Support Kit: Abemaciclib
Last Updated: 04/11/2025
Video
Video
Video
Video
Video: Akynzeo® (Ready-to-Use Vial): A Step-by-Step Video Guide
Last Updated: 02/11/2026
Video: Ibrutinib-Related Cardiac Toxicities: Management & Dose Modifications
Last Updated: 02/11/2026
Video: Neratinib for Extended Adjuvent Treatment of Adult Patients with Early-Stage HER2-Positive Breast Cancer (MIP)
Last Updated: 02/11/2026
Video: BRUKINSA® (Zanubrutinib) for Treatment of Relapsed or Refractory Marginal Zone Lymphoma
Last Updated: 02/11/2026
Patient Education Sheet
PQI
PQI
PQI in Action
Understanding Diarrhea During Cancer Treatment
Last Updated: 09/29/2025
PQI: Oncolytic Induced Diarrhea
Last Updated: 05/22/2024
PQI: Telotristat Ethyl (Xermelo®) for the Management of Carcinoid Syndrome Diarrhea
Last Updated: 11/29/2023
PQI in Action: Telotristat Ethyl: Carcinoid Syndrome Diarrhea
Last Updated: 11/01/2020
PQI
PQI
PQI
PQI
PQI: Granisetron Transdermal System (Sancuso®) for Chemotherapy Induced Nausea and Vomiting
Last Updated: 05/28/2024
PQI: Chemotherapy-Induced Nausea and Vomiting
Last Updated: 05/28/2024
PQI: Netupitant/Fosnetupitant and Palonosetron (Akynzeo®) for Chemotherapy-Induced Nausea and Vomiting
Last Updated: 12/22/2023
PQI: Olanzapine (Zyprexa®) In Chemotherapy Induced Nausea and Vomiting
Last Updated: 11/13/2023
PQI
PQI in Action
Patient Education Sheet
PQI: HER2 Immunohistochemistry Testing in Metastatic Breast Cancer: Guiding Treatment Decisions and the Role of Sacituzumab Govitecan
Last Updated: 02/04/2026
PQI in Action: Sacituzumab Govitecan (Trodelvy®): Management of Neutropenia and Diarrhea
Last Updated: 02/01/2024
Sacituzumab Govitecan
Last Updated: 03/10/2023
PQI
PQI in Action
Patient Education Sheet
PQI: HER2 Immunohistochemistry Testing in Metastatic Breast Cancer: Guiding Treatment Decisions and the Role of Sacituzumab Govitecan
Last Updated: 02/04/2026
PQI in Action: Sacituzumab Govitecan (Trodelvy®): Management of Neutropenia and Diarrhea
Last Updated: 02/01/2024
Sacituzumab Govitecan
Last Updated: 03/10/2023